Literature DB >> 3021902

High-affinity receptor sites and rapid proteolytic inactivation of neurotensin in primary cultured neurons.

F Checler, J Mazella, P Kitabgi, J P Vincent.   

Abstract

The present article describes the interaction of neurotensin with specific receptors in pure primary cultured neurons and the mechanisms by which this peptide is inactivated by these cells. Neurotensin binding sites are not detectable in nondifferentiated neurons and appear during maturation. The binding at 37 degrees C of [monoiodo-Tyr3]neurotensin to monolayers of neurons 96 h after plating is saturable and characterized by a dissociation constant of 300 pM and a maximal binding capacity of 178 fmol/mg of protein. The binding parameters as well as the specificity of these receptors toward neurotensin analogues reveal close similarities between the binding sites present in primary cultured neurons and those described in other membrane preparations or cells. Neurotensin is rapidly degraded by primary cultured neurons. The sites of primary inactivating cleavages are the Pro7-Arg8, Arg8-Arg9, and Pro10-Tyr11 bonds. Proline endopeptidase is totally responsible for the cleavage at the Pro7-Arg8 bond and contributes to the hydrolysis mainly at the Pro10-Tyr11 site. However, the latter breakdown is also generated by a neurotensin-degrading neutral metallopeptidase. The cleavage at the Arg8-Arg9 bond is due to a peptidase that can be specifically inhibited by N-[1(R,S)-carboxy-2-phenylethyl]-alanyl-alanyl-phenylalanyl-p- aminobenzoate. The secondary processing occurring on neurotensin degradation products are: a bestatin-sensitive aminopeptidasic conversion of neurotensin11-13 to free Tyr11, and a rapid cleavage of neurotensin8-13 by proline endopeptidase. A model for the inactivation of neurotensin in primary cultured neurons is proposed and compared to that previously described for purified rat brain synaptic membranes.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3021902     DOI: 10.1111/j.1471-4159.1986.tb13083.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  7 in total

1.  Tissue distribution of a novel neurotensin-degrading metallopeptidase. An immunological approach using monospecific polyclonal antibodies.

Authors:  F Checler; H Barelli; J P Vincent
Journal:  Biochem J       Date:  1989-01-15       Impact factor: 3.857

2.  Distinct properties of neuronal and astrocytic endopeptidase 3.4.24.16: a study on differentiation, subcellular distribution, and secretion processes.

Authors:  B Vincent; A Beaudet; P Dauch; J P Vincent; F Checler
Journal:  J Neurosci       Date:  1996-08-15       Impact factor: 6.167

Review 3.  Neurotensin receptors: binding properties, transduction pathways, and structure.

Authors:  J P Vincent
Journal:  Cell Mol Neurobiol       Date:  1995-10       Impact factor: 5.046

Review 4.  Neurolysin: From Initial Detection to Latest Advances.

Authors:  Frédéric Checler; Emer S Ferro
Journal:  Neurochem Res       Date:  2018-08-29       Impact factor: 3.996

5.  Phosphorus-containing peptides as mixed inhibitors of endopeptidase 3.4.24.15 and 3.4.24.16: effect on neurotensin degradation in vitro and in vivo.

Authors:  B Vincent; V Dive; A Yiotakis; C Smadja; R Maldonado; J P Vincent; F Checler
Journal:  Br J Pharmacol       Date:  1995-07       Impact factor: 8.739

6.  Neurotensin inversely modulates maternal aggression.

Authors:  S C Gammie; K L D'Anna; H Gerstein; S A Stevenson
Journal:  Neuroscience       Date:  2008-12-07       Impact factor: 3.590

7.  Retroinverso analogs of spadin display increased antidepressant effects.

Authors:  Julie Veyssiere; Hamid Moha Ou Maati; Jean Mazella; Georges Gaudriault; Sébastien Moreno; Catherine Heurteaux; Marc Borsotto
Journal:  Psychopharmacology (Berl)       Date:  2014-08-02       Impact factor: 4.530

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.